Trials / Conditions / Acute Spinal Cord Injury

Acute Spinal Cord Injury

28 registered clinical trials studyying Acute Spinal Cord Injury — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study NCT06452264	Kessler Foundation	N/A
Recruiting	A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI NCT06238492	Kessler Foundation	N/A
Recruiting	Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI) NCT05731986	Kessler Foundation	N/A
Recruiting	Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury NCT06654804	University of Washington	Phase 4
Recruiting	The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaide NCT05745298	University of Miami	N/A
Recruiting	"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation NCT05244408	University of British Columbia	—
Unknown	Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial NCT04811235	University of British Columbia	N/A
Recruiting	Spinal Cord Injury Neuroprotection With Glyburide NCT05426681	Francis Farhadi	Phase 1
Completed	Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury NCT05524103	AlaMab Therapeutics (Shanghai) Inc.	Phase 1
Unknown	Stem Cells in Spinal Cord Injury NCT03935724	Neuroplast	Phase 2 / Phase 3
Recruiting	Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI NCT06000592	Jill M. Wecht, Ed.D.	N/A
Recruiting	TSCS for Acute SCI NCT05305118	Icahn School of Medicine at Mount Sinai	N/A
Completed	Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery NCT05255679	University of Alberta	N/A
Unknown	Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury NCT04475224	Kringle Pharma, Inc.	Phase 3
Unknown	Spasticity and Functional Recovery After SCI NCT06030531	Shirley Ryan AbilityLab	—
Unknown	Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study NCT03911492	University of British Columbia	N/A
Recruiting	PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury NCT04054414	Pharmazz, Inc.	Phase 2
Completed	tSCI Contrast Enhanced Ultrasound Study NCT04056988	University of Washington	Phase 4
Terminated	Spinal Cord Injury Neuroprotection With Glyburide NCT02524379	Ohio State University	Phase 1 / Phase 2
Unknown	Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients NCT02510365	Chinese Academy of Sciences	Phase 1
Completed	Prevention of Bone Loss After Acute SCI by Zoledronic Acid NCT02325414	Northwestern University	Phase 2
Terminated	AC105 in Patients With Acute Traumatic Spinal Cord Injury NCT01750684	Acorda Therapeutics	Phase 2
Unknown	Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment NCT02034669	Tri Phuoc Biotechnology., JSC	Phase 1 / Phase 2
Terminated	Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury NCT02232165	University of Calgary	N/A
Completed	Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acut NCT01502631	Daiichi Sankyo	Phase 2
Completed	Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. NCT02260713	Indian Spinal Injuries Centre	Phase 1 / Phase 2
Completed	Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With NCT00406016	Novartis	Phase 1
Completed	Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. NCT00150696	Toronto Rehabilitation Institute	Phase 3